Immune Design Corp.
IMDZ
IMDZ was delisted on the 1st of April, 2019.
60 hedge funds and large institutions have $82.3M invested in Immune Design Corp. in 2016 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 22 increasing their positions, 17 reducing their positions, and 8 closing their positions.
29% more repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 17
13% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 8
2% more funds holding
Funds holding: 59 → 60 (+1)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
36% less capital invested
Capital invested by funds: $130M → $82.3M (-$47.2M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
+$8.26M |
| 2 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$3.04M |
| 3 |
A
Abingworth
London,
United Kingdom
|
+$2.46M |
| 4 |
JP Morgan Chase
New York
|
+$1.29M |
| 5 |
TC
TFS Capital
West Chester,
Pennsylvania
|
+$622K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$11.1M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$9.08M |
| 3 |
Jennison Associates
New York
|
-$2.18M |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$990K |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$187K |
IMDZ Hedge Fund Activity: Q2 2016 in Review
60 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Immune Design Corp. (IMDZ) for Q2 2016, worth a combined $82.3M — down 36% from $130M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new IMDZ positions and 8 closed out — a net gain of 1 holder — while 22 added to existing stakes and 17 trimmed.
The largest buyer was Pictet Asset Management (UK), adding an estimated $8.26M. The largest seller was Sectoral Asset Management, exiting entirely with an estimated $11.1M sold.
- 60 institutional investors held Immune Design Corp. (IMDZ) as of Q2 2016, up from 59 in Q1 2016.
- Funds reported $82.3M of Immune Design Corp. stock for Q2 2016, down 36% quarter-over-quarter.
- 9 funds opened new Immune Design Corp. positions in Q2 2016 and 8 closed out, a net change of +1 holder.
- The largest Immune Design Corp. buyer in Q2 2016 was Pictet Asset Management (UK), an estimated $8.26M added.
- The largest Immune Design Corp. seller in Q2 2016 was Sectoral Asset Management, an estimated $11.1M sold.
Based on aggregated 13F filings for Q2 2016.